• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

GED completes Vitro exit in single asset vehicle deal
GED completes Vitro exit in single asset vehicle deal

GP reaps gross return of 4.0x invested capital and 38% IRR; deal follows sale of Vitro subsidiary to trade in January

  • Secondaries
  • 10 March 2022
Cinven buys Bayer's Environmental Science Professional for EUR 2.4bn
Cinven buys Bayer's Environmental Science Professional for EUR 2.4bn

It is the third industrial carve out by the GP since 2020

  • Buyouts
  • 10 March 2022
Nord Holding launches Small-Cap Fund
Nord Holding launches Small-Cap Fund

Small-Cap strategy will be led from Frankfurt by former VR Equitypartner executive Jan Markus Drees

  • Buyout
  • 09 March 2022
CVC collects first round bids for Theramex
CVC collects first round bids for Theramex

Rothschild and HSBC are advising on the sale of the UK-based womenт€™s health pharma company

  • Exits
  • 09 March 2022
Limerston exits Prism to Charme
Limerston exits Prism to Charme

Charme will complete the deal through Charme IV, which has raised EUR 700m to date

  • Healthcare
  • 03 March 2022
Gilde Equity Management explores Avinty exit advised by Arma
Gilde Equity Management explores Avinty exit advised by Arma

Sale documents for the Dutch healthcare software provider are expected in Q2 2022

  • Exits
  • 03 March 2022
Doxx to collect initial bids amid fierce midmarket sponsor interest
Doxx to collect initial bids amid fierce midmarket sponsor interest

German digital healthcare staffing specialist has attracted GPs such as IK, DPE, Ardian, Chequers, Triton, PAI, Equistone, Rivean Capital

  • Buyouts
  • 28 February 2022
Evoco makes three-company Austrian portfolio deal
Evoco makes three-company Austrian portfolio deal

Deal sees the GP acquire companies from AWS Mittelstandsfonds including medical technology firm AMI

  • Buyouts
  • 24 February 2022
Palamon to carve out Dental Directory from IDH Group
Palamon to carve out Dental Directory from IDH Group

Adviser DC Advisory has distributed materials marketing the asset off GBP 15m EBITDA

  • Exits
  • 24 February 2022
Motion readies Minlay for sale advised by Natixis Partners
Motion readies Minlay for sale advised by Natixis Partners

Apax, Charterhouse and IK are eyeing the French dental prosthetic devices company

  • Exits
  • 24 February 2022
IK small cap fund invests in Sofia
IK small cap fund invests in Sofia

The company has EUR 20m of revenue.

  • Healthcare
  • 23 February 2022
Axcel exits Aidian to Nordstjernan
Axcel exits Aidian to Nordstjernan

The GP had also been planning a Helsinki listing

  • Healthcare
  • 22 February 2022
Triton partially exits Aleris to EQT Infrastructure for EUR 286m
Triton partially exits Aleris to EQT Infrastructure for EUR 286m

The GP has sold the radiology arm for 11x EBITDA.

  • Healthcare
  • 22 February 2022
UCB, Ysios lead EUR 50m Series A for SpliceBio
UCB, Ysios lead EUR 50m Series A for SpliceBio

Round for the gene therapy specialist is the largest ever Series A for a Spanish biotechnology company

  • Expansion
  • 16 February 2022
Pictet holds first close for healthcare fund-of-funds
Pictet holds first close for healthcare fund-of-funds

Around 40% of the target USD 400m will be allocated to co- and direct investments

  • Fund-of-funds
  • 16 February 2022
Astorg closes Mid-Cap Fund on EUR 1.3bn
Astorg closes Mid-Cap Fund on EUR 1.3bn

Fund will target EUR 150m-500m EV deals, expanding on Astorgт€™s current flagship strategy

  • Buyout
  • 15 February 2022
Vaaka buys Medbase as fund III approaches full deployment
Vaaka buys Medbase as fund III approaches full deployment

The GP made the deal from its Buyout III fund

  • Nordics
  • 15 February 2022
Cathay Capital readies Cenexi for exit
Cathay Capital readies Cenexi for exit

Natixis and Jefferies will advise on the upcoming sale of the French CDMO specialised in high sterile products

  • Exits
  • 15 February 2022
LSP closes LSP 7 at EUR 1bn
LSP closes LSP 7 at EUR 1bn

The GP says it is the largest life sciences venture capital fund ever raised in Europe

  • Funds
  • 14 February 2022
Gilde Healthcare buys Europin
Gilde Healthcare buys Europin

The GP will merge it with portfolio company Acti-Med

  • DACH
  • 11 February 2022
Warburg Pincus, Mubadala buy Informa's Pharma Intelligence for GBP 1.9bn
Warburg Pincus, Mubadala buy Informa's Pharma Intelligence for GBP 1.9bn

GPs pay 20-25x EBITDA for the asset, according to two sources close

  • Buyouts
  • 10 February 2022
Lauxera closes first health tech fund on EUR 260m
Lauxera closes first health tech fund on EUR 260m

Debut fund will invest EUR 20m-40m in European and US health technology companies

  • France
  • 09 February 2022
EQT, Verdane exit Forsta to Press Ganey
EQT, Verdane exit Forsta to Press Ganey

Forsta was formed through the merger of Confirmit and FocusVision in March 2021

  • Healthcare
  • 08 February 2022
Abac exits PronoKal to Nestlé Health Science for EUR 100m
Abac exits PronoKal to Nestlé Health Science for EUR 100m

GP first bought 100% of the share capital in 2017

  • Buyouts
  • 07 February 2022
121314
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013